BeyondSpring Inc. Repayments of Debt
BeyondSpring Inc. (BYSI) reported Repayments of Debt of $4.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-08-14
- BeyondSpring Inc. repayments of debt for the quarter ending 2026-06-30 was $74.00K.
- BeyondSpring Inc. repayments of debt for the quarter ending 2026-03-31 was $4.43M.
- BeyondSpring Inc. repayments of debt for the quarter ending 2025-06-30 was $0.00.
- BeyondSpring Inc. repayments of debt for the quarter ending 2025-03-31 was $0.00.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month |
|---|---|---|
| 2026-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.50M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.43M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |